Located in Plymouth Michigan, Tissue Regeneration Systems (TRS) is a start-up medical device company commercializing a breakthrough skeletal reconstruction and bone regeneration technology platform licensed from the Universities of Michigan and Wisconsin. Our technology has been validated by numerous in vitro and in vivo studies, including several large animal trials with very promising long term results. We have completed all required bench and animal testing and received 510K clearance from the FDA for our technology platform and first commercial product. In order to fully capitalize on the broad range of clinical opportunities for our technology platform, TRS has chosen to pursue a corporate partnership business model. We have established a fully integrated, FDA-compliant manufacturing operation to support this strategy.